EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study

Zafer Tandogdu, Bela Koves, Slobodan Ristovski, Mustafa Bahadir Can Balci, Kristin Rennesund, Stavros Gravas, DjordJe Nale, José Medina-Polo, Mária Kopilec Garabášová, Elisabetta Costantini, Jorge Cano-Valasco, Maja Sofronievska Glavinova und 7 weitere

World Journal of Urology · 10.05.2024 · 42 (1)

DOI: 10.1007/s00345-024-04979-2 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift World Journal of Urology, online erschienen am 10.05.2024. Verfasst von Zafer Tandogdu und 18 weiteren Autor:innen. Beteiligte Einrichtung: University College London Hospitals, London, UK. drzafer@gmail.com. Hauptthemen laut MEDLINE: Urinary Tract Infections, Sepsis. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Association of Urology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To provide a descriptive report of mortality and morbidity in the first 30 days of diagnosis of urosepsis. Secondary aim is to identify risk factors of unfavourable outcomes.

Methods

Prospective observational multicentre cohort study conducted from September 2014 to November 2018 in European hospitals. Adult patients (≥ 18 years) diagnosed with acute urosepsis according to Sepsis-2 criteria with confirmed microbiological infection were included. Outcomes were classified in one of four health states: death, multiple organ failure, single organ failure, and recovery at day 30 from onset of urosepsis. Descriptive statistics and ordinal logistic regression analysis was performed.

Results

Three hundred and fifty four patients were recruited, and 30-day mortality rate was 2.8%, rising to 4.6% for severe sepsis. All patients who died had a SOFA score of ≥ 2 at diagnosis. Upon initial diagnosis, 79% ( n = 281) of patients presented with OF. Within 30 days, an additional 5% developed OF, resulting in a total of 84% affected. Charlson score (OR 1.14 CI 1.01–1.28), patients with respiratory failure at baseline (OR 2.35, CI 1.32–4.21), ICU admission within the past 12 months (OR 2.05, CI 1.00–4.19), obstruction causative of urosepsis (OR 1.76, CI 1.02–3.05), urosepsis with multi-drug-resistant(MDR) pathogens (OR 2.01, CI 1.15–3.53), and SOFA baseline score ≥ 2 (OR 2.74, CI 1.49–5.07) are significantly associated with day 30 outcomes (OF and death).

Conclusions

Impact of comorbidities and MDR pathogens on outcomes highlights the existence of a distinct group of patients who are prone to mortality and morbidity. These findings underscore the need for the development of pragmatic classifications to better assess the severity of UTIs and guide management strategies. Study registration : Clinicaltrials.gov registration number NCT02380170.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsSepsisHumansProspective StudiesFemaleMaleRisk FactorsAgedMiddle AgedTime FactorsAged, 80 and overCohort Studies

Stichwörter der Autor:innen

Antibiotic resistanceSevere UTIUrosepsis

Autor:innen und Institutionen

  • University College London Hospitals, London, UK. drzafer@gmail.com.
  • Division of Surgery and Interventional Science, University College London, Charles Bell Housr, London, UK. drzafer@gmail.com.
  • South Pest Teaching Hospital, Budapest, Hungary.
  • University Clinic for Surgical Diseases "St. Naum Ohridski" Skopje, Skopje, Republic of North Macedonia.
  • Gaziosmanpasa Taksim Teaching Hospital, Istanbul, Turkey.
  • Urology Department, Oslo University Hospital, Oslo, Norway.

Förderung

  • European Association of Urology Research Foundation

Zitieren

APA

Tandogdu, Z., Koves, B., Ristovski, S., Balci, M. B. C., Rennesund, K., Gravas, S., Nale, D., Medina-Polo, J., Garabášová, M. K., Costantini, E., Cano-Valasco, J., Glavinova, M. S., Bruyere, F., Perepanova, T., Kulchavenya, E., Cek, M., Wagenlehner, F., Johansen, T. E. B., & SERPENS Investigators (2024). Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-04979-2

Vancouver

Tandogdu Z, Koves B, Ristovski S, Balci MBC, Rennesund K, Gravas S, et al. Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study. World Journal of Urology. 2024;42(1). doi:10.1007/s00345-024-04979-2

BibTeX
@article{Tandogdu2024,
  author = {Tandogdu, Zafer and Koves, Bela and Ristovski, Slobodan and Balci, Mustafa Bahadir Can and Rennesund, Kristin and Gravas, Stavros and Nale, DjordJe and Medina-Polo, José and Garabášová, Mária Kopilec and Costantini, Elisabetta and Cano-Valasco, Jorge and Glavinova, Maja Sofronievska and Bruyere, Franck and Perepanova, Tamara and Kulchavenya, Ekaterina and Cek, Mete and Wagenlehner, Florian and Johansen, Truls Erik Bjerklund and SERPENS Investigators, SERPENS Investigators},
  title = {Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study},
  journal = {World Journal of Urology},
  year = {2024},
  volume = {42},
  number = {1},
  doi = {10.1007/s00345-024-04979-2}
}
Kostenlos starten →